Jin Long Chen - Jan 17, 2023 Form 4 Insider Report for NGM BIOPHARMACEUTICALS INC (NGM)

Role
Chief Scientific Officer, Director
Signature
/s/ Jin-Long Chen
Stock symbol
NGM
Transactions as of
Jan 17, 2023
Transactions value $
-$315,790
Form type
4
Date filed
1/18/2023, 03:06 PM
Previous filing
Jun 13, 2022
Next filing
Mar 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NGM Common Stock Options Exercise $123K +85.1K +9.36% $1.44 994K Jan 17, 2023 Direct F1
transaction NGM Common Stock Sale -$438K -85.1K -8.56% $5.15 909K Jan 17, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NGM Stock Option (Right to Buy) Options Exercise $0 -85.1K -100% $0.00* 0 Jan 17, 2023 Common Stock 85.1K $1.44 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercise occurred because the option was expiring, and shares were sold to pay the exercise price and related tax obligations.
F2 Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $5.015 to $5.30. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
F3 Fully vested.